1. Home
  2. UEIC vs COCH Comparison

UEIC vs COCH Comparison

Compare UEIC & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Electronics Inc.

UEIC

Universal Electronics Inc.

HOLD

Current Price

$4.80

Market Cap

56.6M

ML Signal

HOLD

Logo Envoy Medical Inc.

COCH

Envoy Medical Inc.

HOLD

Current Price

$0.68

Market Cap

51.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEIC
COCH
Founded
1986
1995
Country
United States
United States
Employees
N/A
47
Industry
Consumer Electronics/Appliances
Blank Checks
Sector
Consumer Staples
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
56.6M
51.0M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
UEIC
COCH
Price
$4.80
$0.68
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$3.50
$6.00
AVG Volume (30 Days)
26.4K
293.0K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
23.78
N/A
EPS
N/A
N/A
Revenue
$368,288,000.00
N/A
Revenue This Year
N/A
$1.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.69
$0.36
52 Week High
$5.99
$1.89

Technical Indicators

Market Signals
Indicator
UEIC
COCH
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
UEIC
COCH

About UEIC Universal Electronics Inc.

Universal Electronics Inc is engaged in universal wireless control solutions for the home. The company design, develop, manufacture, ship and support climate control solutions, wireless sensor and smart home control products, home entertainment control products, technology and software solutions and audio-video (AV) accessories that are used by the world's brands in the climate control, security, home automation, home appliance, home entertainment and consumer electronics markets.

About COCH Envoy Medical Inc.

Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.

Share on Social Networks: